AzTrials
AzTrials

Post-partum DepressionNCT01178008

Pilot Study on the Use of Acupuncture for Postpartum Depression

A study testing Active acupuncture in people with Post-partum Depression, run by The University of Hong Kong at 3 sites in Hong Kong.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The proposed study is a randomized controlled trial to examine the efficacy and safety of active acupuncture versus placebo acupuncture for the treatment of postpartum depression. Read more about this study

Who is it for?
Ages 18 years and older, women only
Conditions the study is for
Post-partum Depression
What is being tested?
Active acupuncture
Type of treatment
Surgery or procedure
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
20 participants
Where
3 sitesHong Kong
Study dates
May 2010to Jun 2012
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • Women only
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Ethnic Hong Kong Chinese aged 18 years or above;
  • Within 6 months of giving birth;
  • Edinburgh Postnatal Depression Scale (EPDS) (Cox et al., 1987) score higher than or equal to 12 or being diagnosed as depressed by their obstetrician;
  • Meeting the Diagnostic and Statistical Manual of Mental Disorders-IV diagnosis criteria for major depressive disorder;
  • 17-item Hamilton Depression Rating Scale (HDRS17) (Hamilton, 1960) score of between 12 and 19 at screening and baseline assessment;
  • Willingness to give informed consent and comply with trial protocol.

Who cannot join

  • Suffering from other psychiatric disorders such as schizophrenia, other psychotic disorders, bipolar disorder or substance use disorder;
  • Serious physical illnesses or mental disorders due to a general medical condition which are judged by the investigator to render unsafe;
  • A significant risk of suicide according to the rating of HDRS17 item 3 (score higher than 2), i.e., presence of ideas or gesture of suicide;
  • A presence of idea of self-harming according to the rating of EPDS item 10 (score higher than 0);
  • A significant risk of infanticide according to the investigator assessment;
  • Any acupuncture treatment during the previous 12 months prior to baseline;
Show all 11Show fewer
  • Valvular heart defects, bleeding disorders or taking anticoagulant drugs;
  • Infection or abscess close to the site of selected acupoints;
  • Herbal remedies or psychotropic drugs that are intended for depression are taken within the last 2 weeks prior to baseline or during the study.
  • Receiving counseling or psychological therapies at baseline or during the study;
  • Participation in any clinical trial within the previous 3 months prior to baseline;

Trial locations and contacts

3 sites in 1 country.

Hong Kong3 sites
  • Kwong Wah Hospital

    Hong Kong

  • Queen Mary Hospital

    Hong Kong

  • Tsan Yuk Hospital

    Hong Kong

Other trials in Hong Kong

About this study

The proposed study is a randomized controlled trial to examine the efficacy and safety of active acupuncture versus placebo acupuncture for the treatment of postpartum depression. The investigators hypothesis is that active acupuncture would be superior to placebo acupuncture in the short-term treatment of postpartum depression.

Read the detailed description

This study will be a randomized, controlled, subject- and assessor-blind trial in patients with postpartum depression. Eligible subjects will be randomly assigned to active acupuncture or placebo acupuncture. The subjects will receive acupuncture treatment twice per week for 4 consecutive weeks. The acupuncturist of this trial will not participate in data collection and data entry. The trial assessor will be blind to the subjects' treatment allocation.

Being tested
Active acupuncture, Placebo acupuncture
Keywords
Insomnia, Post-partum Depression, Electroacupuncture, Acupuncture, Randomized Clinical Trial, Traditional Chinese Medicine
Medical subject headings
Depression, Postpartum, Sleep Initiation and Maintenance Disorders

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Active acupunctureProcedure or surgery

    Also called Electroacupuncture

    Active acupuncture regimen consists of electroacupuncture stimulation on cranial and body acupoints which are empirical for treating depression in term of traditional Chinese medicine theory. It is done by a registered Chinese medicine practitioner with at least 3 years experience of providing acupuncture treatment. An electric-stimulator is connected to these needles to give an electric-stimulation in a continuous wave The needles will be left for 30 min and then removed. Acupuncture treatment will consist of two sessions per week for 4 consecutive weeks.

  • Placebo acupunctureProcedure or surgery

    Also called Streitberger needles, Non-invasive acupuncture

    Streitberger's non-invasive acupuncture needles will be applied to serve as placebo control at the same acupoints and the same stimulation modality, except that the needles only affixed on the skin with adhesive tapes instead of insertion. Since all the points used are beyond patients' vision as they lay on bed, they could not visualize the acupuncture procedure. The acupuncturist, setting, treatment frequency, and duration of the treatment course are the same as the active acupuncture group.

Study groups in NCT01178008
Study groupRoleWhat they receive
Active acupuncture groupExperimentalActive acupuncture regimen consists of electroacupuncture stimulation on cranial and body acupoints.
Receives: Procedure: Active acupuncture
Placebo acupuncture groupPlacebo comparatorStreitberger's non-invasive acupuncture needles will be applied to serve as placebo control at the same acupoints and the same stimulation modality, except that the needles only affixed on the skin with adhesive tapes instead of insertion. Since all the points used are beyond patients' vision as they lay on bed, they could not visualize the acupuncture procedure. The acupuncturist, setting, treatment frequency, and duration of the treatment course are the same as the active acupuncture group.
Receives: Procedure: Placebo acupuncture

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. 17-item Hamilton Depression Rating Scale

    To assess Depressive symptoms

    Measured: 8 weeks

Secondary outcomes (4)
  1. Hospital Anxiety and Depression Scale (HADS)

    To assess depression and anxiety

    Measured: 8 weeks

  2. Sheehan Disability Scale

    To assess subjects' functioning in work/study, social life and family

    Measured: 8 weeks

  3. Clinical Global Impression Scale

    To assess severity of illness and improvement due to treatment

    Measured: 8 weeks

  4. Edinburgh Postnatal Depression Scale

    To assess subjective Depressive symptoms

    Measured: 8 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted9 Aug 2010 (estimated)
  2. Study startMay 2010
  3. Primary completionDec 2011
  4. Study completionJun 2012

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Participant, Outcomes assessor
Enrolment
20 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01178008
Sponsor's protocol ID
Acup-003
Status last verified
Jan 2013
First submitted
1 Aug 2010
Last updated
16 Jan 2013
Results posted
No
Data monitoring committee
No

Publications

  • Cox JL, Holden JM, Sagovsky R. Detection of postnatal depression. Development of the 10-item Edinburgh Postnatal Depression Scale. Br J Psychiatry. 1987 Jun;150:782-6. doi: 10.1192/bjp.150.6.782.

    PubMed 3651732
  • HAMILTON M. A rating scale for depression. J Neurol Neurosurg Psychiatry. 1960 Feb;23(1):56-62. doi: 10.1136/jnnp.23.1.56. No abstract available.

    PubMed 14399272
  • Chung KF, Yeung WF, Zhang ZJ, Yung KP, Man SC, Lee CP, Lam SK, Leung TW, Leung KY, Ziea ET, Taam Wong V. Randomized non-invasive sham-controlled pilot trial of electroacupuncture for postpartum depression. J Affect Disord. 2012 Dec 15;142(1-3):115-21. doi: 10.1016/j.jad.2012.04.008. Epub 2012 Jul 26.

    PubMed 22840621

Questions about this trial

What is this clinical trial studying?

A study testing Active acupuncture in people with Post-partum Depression, run by The University of Hong Kong at 3 sites in Hong Kong.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 11 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 16 Jan 2013. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 3 sites in Hong Kong. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

17-item Hamilton Depression Rating Scale (time frame: 8 weeks). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT01178008, which also lists 3 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 16 Jan 2013.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in